Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2014 2
2015 4
2016 3
2017 1
2018 3
2020 5
2021 3
2022 1
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Intensive Supportive Care plus Immunosuppression in IgA Nephropathy.
Rauen T, Eitner F, Fitzner C, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JF, Hilgers RD, Floege J; STOP-IgAN Investigators. Rauen T, et al. N Engl J Med. 2015 Dec 3;373(23):2225-36. doi: 10.1056/NEJMoa1415463. N Engl J Med. 2015. PMID: 26630142 Free article. Clinical Trial.
After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy.
Rauen T, Wied S, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Budde K, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J; STOP-IgAN Investigators. Rauen T, et al. Kidney Int. 2020 Oct;98(4):1044-1052. doi: 10.1016/j.kint.2020.04.046. Epub 2020 May 22. Kidney Int. 2020. PMID: 32450154 Clinical Trial.
Treatment of Fabry Disease management with migalastat-outcome from a prospective 24 months observational multicenter study (FAMOUS).
Lenders M, Nordbeck P, Kurschat C, Eveslage M, Karabul N, Kaufeld J, Hennermann JB, Patten M, Cybulla M, Müntze J, Üçeyler N, Liu D, Das AM, Sommer C, Pogoda C, Reiermann S, Duning T, Gaedeke J, von Cossel K, Blaschke D, Brand SM, Mann WA, Kampmann C, Muschol N, Canaan-Kühl S, Brand E. Lenders M, et al. Among authors: canaan kuhl s. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):272-281. doi: 10.1093/ehjcvp/pvab025. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35512362
Late-onset Bartter syndrome type II.
Gollasch B, Anistan YM, Canaan-Kühl S, Gollasch M. Gollasch B, et al. Among authors: canaan kuhl s. Clin Kidney J. 2017 Oct;10(5):594-599. doi: 10.1093/ckj/sfx033. Epub 2017 May 8. Clin Kidney J. 2017. PMID: 28979772 Free PMC article.
Treatment switch in Fabry disease- a matter of dose?
Lenders M, Nordbeck P, Canaan-Kühl S, Kreul L, Duning T, Lorenz L, Pogoda C, Brand SM, Wanner C, Brand E. Lenders M, et al. Among authors: canaan kuhl s. J Med Genet. 2021 May;58(5):342-350. doi: 10.1136/jmedgenet-2020-106874. Epub 2020 Jun 10. J Med Genet. 2021. PMID: 32522756
Long-term Outcomes of Kidney Transplantation in Fabry Disease.
Ersözlü S, Desnick RJ, Huynh-Do U, Canaan-Kühl S, Barbey F, Genitsch V, Mueller TF, Cheetham M, Flammer AJ, Schaub S, Nowak A. Ersözlü S, et al. Among authors: canaan kuhl s. Transplantation. 2018 Nov;102(11):1924-1933. doi: 10.1097/TP.0000000000002252. Transplantation. 2018. PMID: 29688992 Free article.
Bridging the Gap Between Vessels and Nerves in Fabry Disease.
Forstenpointner J, Sendel M, Moeller P, Reimer M, Canaan-Kühl S, Gaedeke J, Rehm S, Hüllemann P, Gierthmühlen J, Baron R. Forstenpointner J, et al. Among authors: canaan kuhl s. Front Neurosci. 2020 Jun 16;14:448. doi: 10.3389/fnins.2020.00448. eCollection 2020. Front Neurosci. 2020. PMID: 32612493 Free PMC article.
Alpha-Galactosidase A p.A143T, a non-Fabry disease-causing variant.
Lenders M, Weidemann F, Kurschat C, Canaan-Kühl S, Duning T, Stypmann J, Schmitz B, Reiermann S, Krämer J, Blaschke D, Wanner C, Brand SM, Brand E. Lenders M, et al. Among authors: canaan kuhl s. Orphanet J Rare Dis. 2016 May 4;11(1):54. doi: 10.1186/s13023-016-0441-z. Orphanet J Rare Dis. 2016. PMID: 27142856 Free PMC article.
Fabry disease under enzyme replacement therapy-new insights in efficacy of different dosages.
Krämer J, Lenders M, Canaan-Kühl S, Nordbeck P, Üçeyler N, Blaschke D, Duning T, Reiermann S, Stypmann J, Brand SM, Gottschling T, Störk S, Wanner C, Sommer C, Brand E, Weidemann F. Krämer J, et al. Among authors: canaan kuhl s. Nephrol Dial Transplant. 2018 Aug 1;33(8):1362-1372. doi: 10.1093/ndt/gfx319. Nephrol Dial Transplant. 2018. PMID: 29186537
22 results